CD274/PD-L1 expression is reported in TP53-mutated melanoma, non-small cell lung cancer, colorectal cancer, and renal cell carcinoma (Huang et al., 2018; Thiem et al., 2019). This evidence concerns the gene CD274 and non-small cell lung carcinoma.